πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10577368

A3 adenosine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570214

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562960

Neutralizing antibodies to gp120 and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561721

Methods and compositions for inducing protective immunity against filovirus infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561666

Amido compounds as RORΞ³t modulators and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561722

Methods and compositions for enhancing immune responses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561724

Live attenuated virus vaccines for La Crosse virus and other bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561729

Near-IR light-cleavable conjugates and conjugate precursors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562843

Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in tr

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561673

Dendrimer based nanodevices for therapeutic and imaging purposes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562952

Anti-CD276 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10556001

Thermal inactivation of rotavirus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10556916

Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10556940

T cell receptors recognizing HLA-Cw8 restricted mutated KRAS

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10555942

Emetine compounds for treatment and prevention of flavivirus infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548970

Human rotavirus G9P[6] strain and use as a vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548987

Antibody-drug conjugates for targeting CD56-positive tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550164

Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and the

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10544392

Methods of isolating T cells and T cell receptors having antigenic specificity for a cance

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10543257

Lentiviral vector for treating hemoglobin disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10519222

Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10517890

Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10512671

IL-24 to treat inflammatory diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10512673

Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted